Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Recruiting 16Completed 7Not yet recruiting 6Active not recruiting 5Unknown 3Withdrawn 1Terminated 1Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Genitourinary 2Dermatologic 2Other 1Head & Neck 1Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 2Squamous Cell Carcinoma of Head and Neck 1Non Small Cell Lung Cancer Metastatic 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Acute Graft Versus Host Disease 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Fecal Microbiota Transplantation × Clear all
NCT06026371 2026-01-12

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
138 enrolled
Other

Acute Graft Versus Host Disease

NCT04729322 2025-12-23

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
15 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04163289 2025-09-15

PERFORM

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Active not recruiting
20 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05286294 2025-07-03

MITRIC

Oslo University Hospital

Phase 2 Active not recruiting
20 enrolled
DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT04951583 2024-08-07

FMT-LUMINATE

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Active not recruiting
45 enrolled
DermatologicThoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡